<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Front Oncol</journal-id><journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id><journal-title-group><journal-title>Frontiers in Oncology</journal-title></journal-title-group><issn pub-type="epub">2234-943X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40134597</article-id><article-id pub-id-type="pmc">PMC11933651</article-id>
<article-id pub-id-type="doi">10.3389/fonc.2025.1516995</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oncology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Histogram analysis of continuous-time random walk and restrictive spectrum imaging for identifying hepatocellular carcinoma and intrahepatic cholangiocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Dai</surname><given-names>Bo</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2878356"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhou</surname><given-names>Yihang</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn003" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Lei</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Hanhan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Ting</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1677173"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Jiayin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Yan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/600972"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Mao</surname><given-names>Wei</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Xiaopeng</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/286042"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yan</surname><given-names>Fengshan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/validation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Meiyun</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Radiology, Henan Provincial People&#x02019;s Hospital &#x00026; Zhengzhou University People&#x02019;s Hospital</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Department of Radiology, Xinxiang Medical University People's Hospital &#x00026; Henan Provincial People's Hospital</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Department of Radiology, West China School of Public Health and West China Fourth Hospital</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>Central Research Institute, United Imaging Healthcare</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Biomedical Research Institute, Henan Academy of Sciences</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff><aff id="aff6">
<sup>6</sup>
<institution>Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Abhishek Mahajan, The Clatterbridge Cancer Centre, United Kingdom</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ruiping Zheng, First Affiliated Hospital of Zhengzhou University, China</p><p>Basen Li, Huazhong University of Science and Technology, China</p></fn><corresp id="fn001">*Correspondence: Bo Dai, <email xlink:href="mailto:daibo202109@163.com">daibo202109@163.com </email>; Fengshan Yan, <email xlink:href="mailto:mountyan857@163.com">mountyan857@163.com</email>; Meiyun Wang, <email xlink:href="mailto:mywang@zzu.edu.cn">mywang@zzu.edu.cn</email>
</corresp><fn fn-type="equal" id="fn003"><p>&#x02020;These authors have contributed equally to this work and share first authorship</p></fn></author-notes><pub-date pub-type="epub"><day>10</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><elocation-id>1516995</elocation-id><history><date date-type="received"><day>25</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Dai, Zhou, Shen, Li, Fang, Pan, Wang, Mao, Song, Yan and Wang</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Dai, Zhou, Shen, Li, Fang, Pan, Wang, Mao, Song, Yan and Wang</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><sec><title>Background</title><p>To compare the ability and potential additional value of various diffusion models, including continuous-time random walk (CTRW), restrictive spectrum imaging (RSI), and diffusion-weighted imaging (DWI), as well as their associated histograms, in distinguishing the pathological subtypes of liver cancer.</p></sec><sec><title>Methods</title><p>40 patients with liver cancer were included in this study. Histogram metrics were derived from CTRW (D, &#x003b1;, &#x003b2;), RSI (f<sub>1</sub>, f<sub>2</sub>, f<sub>3</sub>), and DWI (ADC) parameters across the entire tumor volume. Statistical analyses included the Chi-square test, independent samples t-test, Mann-Whitney U test, ROC, logistic regression, and Spearman correlation.</p></sec><sec><title>Results</title><p>Patients with hepatocellular carcinoma exhibited higher values in f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub>, and f<sub>1 60th</sub> compared to patients with intrahepatic cholangiocarcinoma, whereas D<sub>mean</sub>, D<sub>median</sub>, D<sub>40th</sub>, D<sub>60th</sub>, and D<sub>80th</sub> percentiles were lower (P&#x0003c;0.05). Among the individual histogram parameters, f<sub>1 40th</sub> percentile demonstrated the highest accuracy (AUC = 0.717). Regarding the combined and single models, the total combined model exhibited the best diagnostic performance (AUC = 0.792). Although RSI showed higher diagnostic efficacy than CTRW (AUC = 0.731, 0.717), the combination of CTRW and RSI further improved diagnostic performance (AUC = 0.787), achieving superior sensitivity and specificity (sensitivity = 0.72, specificity = 0.80).</p></sec><sec><title>Conclusion</title><p>CTRW, RSI, and their corresponding histogram parameters demonstrated the ability to distinguish between pathological subtypes of liver cancer. Moreover, whole-lesion histogram parameters provided more comprehensive statistical insights compared to mean values alone.</p></sec></abstract><kwd-group><kwd>continuous-time random walk</kwd><kwd>restrictive spectrum imaging</kwd><kwd>whole-lesion histogram</kwd><kwd>hepatocellular carcinoma</kwd><kwd>intrahepatic cholangiocarcinoma</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Key R&#x00026;D Program of China (2023YFC2414200), National Natural Science Foundation of China (82371934), Medical Science and Technology Research Project of Henan Province (SBGJ202101002), Joint Fund of Henan Province Science and Technology R&#x00026;D Program (225200810062).</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="4"/><equation-count count="3"/><ref-count count="34"/><page-count count="11"/><word-count count="4819"/></counts><custom-meta-group><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Cancer Imaging and Image-directed Interventions</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Liver cancer is one of the leading causes of cancer-related deaths globally, with incidence and mortality rates steadily increasing (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, accounting for 90% of cases, while intrahepatic cholangiocarcinoma (ICC) makes up 10-15% (<xref rid="B1" ref-type="bibr">1</xref>). Compared to HCC, ICC is more aggressive and has a higher potential for metastasis, resulting in differences in treatment and prognosis (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). On dynamic contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI), ICC can present imaging features similar to those typical of HCC, making differentiation complex and time-consuming, even for experienced specialists (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Additionally, the use of contrast agents is costly and may be contraindicated in certain patients (<xref rid="B7" ref-type="bibr">7</xref>). A biopsy is also a common method for distinguishing pathological subtypes of liver cancer. However, this approach is invasive and has several drawbacks, including low patient compliance and a high rate of complication. Thus, the development of a non-invasive technique to accurately differentiate pathological subtypes of liver cancer remains a significant challenge.</p><p>DWI, the pioneering diffusion imaging technique employed in clinical practice, quantifies the extent of restricted diffusion motion of water molecules through the quantitative parameter known as the apparent diffusion coefficient (ADC) (<xref rid="B8" ref-type="bibr">8</xref>). Study has demonstrated that ADC can serve as a potential surrogate imaging biomarker for distinguishing HCC, ICC, and metastatic cancer (<xref rid="B9" ref-type="bibr">9</xref>). However, DWI assumes a Gaussian distribution of the diffusion motion of water molecules in biological tissues, which makes it unable to fully capture the non-Gaussian characteristics of water diffusion in complex subcellular microstructures, which in turn leads to limitations in the accuracy of ADC value assessment (<xref rid="B10" ref-type="bibr">10</xref>). To obtain more accurate information on water diffusion and to map tissue microstructure, researchers have developed non-Gaussian mathematical models based on high b-value DWI, such as the continuous-time random walk (CTRW) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). The CTRW provides three parameters: diffusion coefficient (D), temporal diffusion heterogeneity (&#x003b1;), and spatial diffusion heterogeneity (&#x003b2;). The D describes the non-Gaussian diffusion behavior in biological tissues, while &#x003b1; and &#x003b2; are related to temporal and spatial diffusion heterogeneity, respectively. Both parameters may reflect different aspects of tissue structural heterogeneity within the voxel (<xref rid="B13" ref-type="bibr">13</xref>). Currently, CTRW has demonstrated significant potential in distinguishing benign from malignant breast lesions, identifying pathological subtypes, and evaluating prognosis (<xref rid="B14" ref-type="bibr">14</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>). However, reports on the use of CTRW to assess the severity of liver fibrosis and liver cancer metastasis are limited (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Various DWI techniques encounter the challenge of significant overlap between diffusion signals due to the mixed signals from intracellular and extracellular water molecule diffusion (<xref rid="B18" ref-type="bibr">18</xref>). A novel diffusion-weighted magnetic resonance imaging technique, known as restriction spectrum imaging (RSI), addresses this issue (<xref rid="B19" ref-type="bibr">19</xref>). In the three-compartment model, each compartment represents a different water molecule diffusion, f<sub>1</sub> indicates the signal fraction of restricted diffusion, reflecting the tumor&#x02019;s cellular composition; f<sub>2</sub> represents the signal fraction of hindered diffusion, indicating delayed water molecule passage around cellular obstacles; and f<sub>3</sub> represents the signal fraction of free water diffusion, reflecting microcirculation perfusion (<xref rid="B20" ref-type="bibr">20</xref>). RSI can isolate areas of truly restricted diffusion by separating and removing hindered diffusion signals, offering a more direct measurement of tumor cells compared to other diffusion-weighted methods (<xref rid="B19" ref-type="bibr">19</xref>). RSI has achieved significant breakthroughs in distinguishing benign from malignant tumors and has demonstrated potential in differentiating cancerous from non-cancerous tissues in studies involving lungs, prostate, and breast (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). However, the relative value of CTRW and RSI in distinguishing pathological subtypes of liver cancer has not been compared. Histogram is a classical analysis method based on image voxel values, which not only has high reproducibility and consistency, but also can provide additional quantitative indicators (<xref rid="B22" ref-type="bibr">22</xref>&#x02013;<xref rid="B24" ref-type="bibr">24</xref>). Therefore, if histogram analysis is applied to RSI and CTRW, it is expected to mine richer image information and thus provide more evidence for ICC and HCC identification.</p><p>The objective of this study was to compare the value of RSI, CTRW and DWI and their associated histograms in differentiating HCC from ICC, with the aim of finding an accurate, non-invasive imaging marker to guide clinical decision making.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and methods</title><sec id="s2_1"><title>Participants</title><p>This prospective study received approval from the Research Ethics Committee and obtained written informed consent from all participating patients. From March 2022 to March 2024, a total of 70 patients diagnosed with focal liver lesions (FLLs) underwent liver MRI examinations. Patient demographic data were collected from electronic medical records. Inclusion criteria are as follows: (1) patients with pathologically confirmed HCC or ICC; (2) those without MRI contraindications, such as cardiac pacemakers, ferromagnetic implants, or claustrophobia. exclusion criteria are as follows: (1) patients who had undergone prior local treatment for liver tumors, such as resection, transplantation, chemotherapy, trans arterial chemoembolization, radiofrequency ablation, or immunosuppressive therapy; (2) patients with non-liver primary lesions and those whose image quality was compromised by ghosting, distortion artifacts, or respiratory motion artifacts, making it impossible to delineate the FLLs. The flowchart for this selection process is illustrated in <xref rid="f1" ref-type="fig">
<bold>Figure&#x000a0;1</bold>
</xref>.</p><fig position="float" id="f1"><label>Figure&#x000a0;1</label><caption><p>Flow diagram of the study population.</p></caption><graphic xlink:href="fonc-15-1516995-g001" position="float"/></fig></sec><sec id="s2_2"><title>Image acquisition</title><p>All initially enrolled patients underwent MRI examinations using a 3.0 T MRI scanner (uMR790, United Imaging Healthcare, Shanghai, China) equipped with a 12-channel phased-array body coil. Patients were positioned in a supine, head-first orientation. Initially, routine axial T<sub>1</sub>-weighted and axial and coronal T<sub>2</sub>-weighted images were acquired. Subsequently, diffusion-weighted images with multiple b-values were obtained. The detailed MRI parameters are provided in <xref rid="T1" ref-type="table">
<bold>Table&#x000a0;1</bold>
</xref>.</p><table-wrap position="float" id="T1"><label>Table&#x000a0;1</label><caption><p>MR Scanning Parameters.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Parameter</th><th valign="middle" align="center" rowspan="1" colspan="1">T<sub>1</sub>WI</th><th valign="middle" align="center" rowspan="1" colspan="1">T<sub>2</sub>WI</th><th valign="middle" align="center" rowspan="1" colspan="1">T<sub>2</sub>WI</th><th valign="middle" align="center" rowspan="1" colspan="1">Multiple b-value DWI</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">TR (ms)</td><td valign="middle" align="center" rowspan="1" colspan="1">3.98</td><td valign="middle" align="center" rowspan="1" colspan="1">4190</td><td valign="middle" align="center" rowspan="1" colspan="1">4190</td><td valign="middle" align="center" rowspan="1" colspan="1">3051</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">TE (ms)</td><td valign="middle" align="center" rowspan="1" colspan="1">1.48</td><td valign="middle" align="center" rowspan="1" colspan="1">93.60</td><td valign="middle" align="center" rowspan="1" colspan="1">97.20</td><td valign="middle" align="center" rowspan="1" colspan="1">92.30</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Flip angle (deg.)</td><td valign="middle" align="center" rowspan="1" colspan="1">12</td><td valign="middle" align="center" rowspan="1" colspan="1">90</td><td valign="middle" align="center" rowspan="1" colspan="1">90</td><td valign="middle" align="center" rowspan="1" colspan="1">90</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Slice thickness (mm)</td><td valign="middle" align="center" rowspan="1" colspan="1">5.0</td><td valign="middle" align="center" rowspan="1" colspan="1">6.0</td><td valign="middle" align="center" rowspan="1" colspan="1">6.0</td><td valign="middle" align="center" rowspan="1" colspan="1">5.0</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">FOV*(mm<sup>2</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">400&#x000d7;280</td><td valign="middle" align="center" rowspan="1" colspan="1">380&#x000d7;280</td><td valign="middle" align="center" rowspan="1" colspan="1">380&#x000d7;380</td><td valign="middle" align="center" rowspan="1" colspan="1">320&#x000d7;200</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Matrix</td><td valign="middle" align="center" rowspan="1" colspan="1">320&#x000d7;320</td><td valign="middle" align="center" rowspan="1" colspan="1">243&#x000d7;304</td><td valign="middle" align="center" rowspan="1" colspan="1">228&#x000d7;304</td><td valign="middle" align="center" rowspan="1" colspan="1">160&#x000d7;160</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Bandwidth (kHz)</td><td valign="middle" align="center" rowspan="1" colspan="1">1260</td><td valign="middle" align="center" rowspan="1" colspan="1">700</td><td valign="middle" align="center" rowspan="1" colspan="1">700</td><td valign="middle" align="center" rowspan="1" colspan="1">1670</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">NEX</td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">1</td><td valign="middle" align="center" rowspan="1" colspan="1">1,1,1,1,1,1,1,1,4,4,6,8,10,12</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">b values (s/mm<sup>2</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">/</td><td valign="middle" align="center" rowspan="1" colspan="1">/</td><td valign="middle" align="center" rowspan="1" colspan="1">/</td><td valign="middle" align="center" rowspan="1" colspan="1">0,25,50,100,150,200,400,600,800,1000,1500,2000,3000</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Orientation</td><td valign="middle" align="center" rowspan="1" colspan="1">Axial</td><td valign="middle" align="center" rowspan="1" colspan="1">Axial</td><td valign="middle" align="center" rowspan="1" colspan="1">Coronal</td><td valign="middle" align="center" rowspan="1" colspan="1">Axial</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Breath control</td><td valign="middle" align="center" rowspan="1" colspan="1">Breath holding</td><td valign="middle" align="center" rowspan="1" colspan="1">Breath holding</td><td valign="middle" align="center" rowspan="1" colspan="1">Breath holding</td><td valign="middle" align="center" rowspan="1" colspan="1">Breathe freely</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Scanning time</td><td valign="middle" align="center" rowspan="1" colspan="1">15.8s</td><td valign="middle" align="center" rowspan="1" colspan="1">33.5s</td><td valign="middle" align="center" rowspan="1" colspan="1">33.5s</td><td valign="middle" align="center" rowspan="1" colspan="1">2.49min</td></tr></tbody></table><table-wrap-foot><fn><p>T<sub>2</sub>WI, T<sub>2</sub>-weighted imaging; T<sub>1</sub>WI, T<sub>1</sub>-weighted imaging; DWI, diffusion weighted imaging; FOV, field of view; NEX, number of excitations; TE, echo time; TR, repetition time.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2_3"><title>Data post-processing</title><p>The parameter from different DWI techniques were calculated using prototype software developed with Python (Python 3.8; Python Software Foundation). These calculations were based on the following formulas.</p><p>(1) The mono-exponential model:</p><disp-formula>
<mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>b</mml:mi></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>exp</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>b</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>x </mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>A</mml:mi><mml:mi>D</mml:mi><mml:mi>C</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math>
</disp-formula><p>In this model, <italic>S</italic>
<sub>0</sub> refers to the signal obtained using a b-value of 0 mm&#x000b2;/s, while S<sub>b</sub> corresponds to the signal obtained using a b-value of 800 mm&#x000b2;/s. ADC denotes the apparent diffusion coefficient (<xref rid="B25" ref-type="bibr">25</xref>).</p><p>(2) The CTRW model:</p><disp-formula>
<mml:math id="M2" display="block" overflow="scroll"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>b</mml:mi></mml:msub><mml:mo stretchy="false">/</mml:mo><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mi>&#x003b1;</mml:mi></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mo>&#x02212;</mml:mo><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>b</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>x </mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math>
</disp-formula><p>In this model, <italic>E</italic>&#x000a0;. dotes the Mittag-Leffler function of order &#x003b1;. D represents an anomalous diffusion coefficient, while &#x003b1; and &#x003b2; are diffusion metrics associated with temporal and spatial diffusion heterogeneity, respectively. Both &#x003b1; and &#x003b2; range from 0 to 1, indicating the degree of homogeneity within the medium (<xref rid="B14" ref-type="bibr">14</xref>).</p><p>(3) The Tri-Compartmental RSI model:</p><disp-formula>
<mml:math id="M3" display="block" overflow="scroll"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>b</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>o</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x000a0;</mml:mo><mml:mi>x </mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>exp</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>b</mml:mi><mml:mo>&#x000b7;</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>&#x000a0;</mml:mo><mml:mi>x </mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>exp</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>b</mml:mi><mml:mo>&#x000b7;</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>&#x000a0;</mml:mo><mml:mi>x </mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mi>exp</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mi>b</mml:mi><mml:mo>&#x000b7;</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math>
</disp-formula><p>In this model, the signal intensities <italic>S</italic>
<sub>b</sub> and <italic>S</italic>
<sub>0</sub> correspond to specific b&#x02013;values, with b = 0 mm&#x000b2;/s D<sub>1</sub>, D<sub>2</sub>, and D<sub>3</sub> represent the diffusion coefficients for restricted, hindered, and free diffusion, respectively. The variables f<sub>1</sub>, f<sub>2</sub>, and f<sub>3</sub> denote the volume fractions of these diffusion components. Restricted diffusion refers to water molecules trapped within intracellular spaces, resulting in very slow diffusion. Hindered diffusion occurs when extracellular water molecules are obstructed by cells, impeding their movement Free diffusion, by contrast, describes the rapid, unrestricted movement of water molecules. Based on reference studies, the optimal diffusion coefficients for D<sub>1</sub>, D<sub>2</sub>, and D<sub>3</sub> were determined to be 0.05 &#x000d7; 10<sup>&#x02212;3</sup> mm<sup>2</sup>/s, 1.25 &#x000d7; 10<sup>&#x02212;3</sup> mm<sup>2</sup>/s, and 20 &#x000d7; 10<sup>&#x02212;3</sup> mm<sup>2</sup>/s, respectively. These values were used to calculate f<sub>1</sub>, f<sub>2</sub>, and f<sub>3</sub> maps. The b-values used for fitting the RSI model were 0, 25, 50, 100, 150, 200, 400, 600, 800, 1000, 1500, 2000, and 3000 s/mm<sup>2</sup> (<xref rid="B26" ref-type="bibr">26</xref>).</p><p>In order to fully reflect the lesion information, all slices containing tumors were selected from DWI images with b = 600 mm&#x000b2;/s, using conventional T<sub>1</sub>-weighted and T<sub>2</sub>-weighted images as references, and regions of interest (ROIs) were manually outlined layer by layer along the edges of the tumors. This process should avoid obvious bleeding, necrosis and other areas as much as possible, and the final volumes of interest (VOIs) were composed of different slices of ROI. Subsequently, VOIs were replicated on D, &#x003b1;, &#x003b2;, f<sub>1</sub>, f<sub>2,</sub> f<sub>3</sub>, and ADC pseudo color maps, and the following histogram indicators were also extracted based on existing studies: mean, median, maximum, minimum, 20th percentile, 40th percentile, 60th percentile, 80th percentile, standard deviation, variance, kurtosis, and skewness (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B27" ref-type="bibr">27</xref>). <xref rid="f2" ref-type="fig">
<bold>Figures&#x000a0;2</bold>
</xref> and <xref rid="f3" ref-type="fig">
<bold>3</bold>
</xref> present representative MRI images of HCC and ICC, respectively. The above work was performed collaboratively by two radiologists (with 8 and 14 years of experience in abdominal imaging diagnosis) who had no prior knowledge of the clinical and pathological data, and in the event of disagreement, the decision was taken by negotiation and ultimately by the more experienced radiologist.</p><fig position="float" id="f2"><label>Figure&#x000a0;2</label><caption><p>A 51-year-old male with hepatocellular carcinoma. <bold>(a-h)</bold> Pseudo-color drawings corresponding to D, &#x003b1;, &#x003b2;, and ADC. <bold>(i-p)</bold> Histograms of D, &#x003b1;, &#x003b2;, and ADC.</p></caption><graphic xlink:href="fonc-15-1516995-g002" position="float"/></fig><fig position="float" id="f3"><label>Figure&#x000a0;3</label><caption><p>A 33-year-old male with Cholangiocarcinoma. <bold>(a-h)</bold> Pseudo-color drawings corresponding to D, &#x003b1;, &#x003b2;, and ADC. <bold>(i-p)</bold> Histograms of D, &#x003b1;, &#x003b2;, and ADC.</p></caption><graphic xlink:href="fonc-15-1516995-g003" position="float"/></fig></sec><sec id="s2_4"><title>Statistical analysis</title><p>All data were statistically analyzed using MedCalc 15.0 (MedCalc Software, Mariakerke, Belgium) and SPSS 26.0 (SPSS, Chicago, IL). The Shapiro-Wilk test and Levene&#x02019;s test were employed to assess the normality of general data and histogram parameters, as well as the equality of variances. The Chi-square test, independent samples t-test, and the Mann-Whitney U test were used to compare differences in general data and quantitative histogram parameters between the HCC and ICC groups. Logistic regression was applied to establish combined models of histogram parameters and various model parameters. Receiver operating characteristic (ROC) curves were used to evaluate the ability of individuals and combined to distinguish pathological subtypes of liver cancer. Diagnostic thresholds, sensitivity, and specificity were determined based on the maximum Youden index. Spearman correlation analysis was conducted to explore correlations between parameters, with correlation coefficients (r) categorized as follows: 0-0.49 for poor correlation, 0.50-0.74 for moderate correlation, and 0.75-1.00 for strong correlation (<xref rid="B11" ref-type="bibr">11</xref>). A significance level of <italic>P&#x0003c;</italic> 0.05 was considered statistically significant for all analyses.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec id="s3_1"><title>Patient characteristics</title><p>Initially, 70 patients diagnosed with FLLs were enrolled in this prospective study. After excluding 30 patients due to preoperative treatment (<italic>N</italic> = 12), non-hepatic primary lesions <italic>(N</italic> = 3), unclear histopathological results (<italic>N</italic> = 4), poor image quality (<italic>N</italic> = 2), and pathological results indicating benign FLLs (<italic>N</italic> = 9), a total of 40 patients were included in the final analysis. The 40 patients had an average age of 57.43 &#x000b1; 10.47 years (range: 33-75 years). Based on histopathological results, 25 patients were diagnosed with HCC and 15 patients were diagnosed with ICC. <xref rid="T2" ref-type="table">
<bold>Table&#x000a0;2</bold>
</xref> presents the detailed patient characteristics.</p><table-wrap position="float" id="T2"><label>Table&#x000a0;2</label><caption><p>Demographics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1"/><th valign="middle" align="center" rowspan="1" colspan="1">HCC</th><th valign="middle" align="center" rowspan="1" colspan="1">ICC</th><th valign="middle" align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">Number of patients</td><td valign="middle" align="center" rowspan="1" colspan="1">25</td><td valign="middle" align="center" rowspan="1" colspan="1">15</td><td valign="middle" align="center" rowspan="1" colspan="1">/</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Gender (M:F)</td><td valign="middle" align="center" rowspan="1" colspan="1">20:5</td><td valign="middle" align="center" rowspan="1" colspan="1">11:4</td><td valign="middle" align="center" rowspan="1" colspan="1">0.705</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Age (year) mean &#x000b1; SD</td><td valign="middle" align="center" rowspan="1" colspan="1">58.04 &#x000b1; 9.96</td><td valign="middle" align="center" rowspan="1" colspan="1">56.4 &#x000b1; 11.55</td><td valign="middle" align="center" rowspan="1" colspan="1">0.638</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">AFP (ng/ml)<break/>Median (IQR)</td><td valign="middle" align="center" rowspan="1" colspan="1">59.85 (6.55, 3740.00)</td><td valign="middle" align="center" rowspan="1" colspan="1">4.13 (2.73, 14.35)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.011*</td></tr><tr><th valign="middle" colspan="4" align="left" rowspan="1">Background liver</th></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Chronic hepatitis B</td><td valign="middle" align="center" rowspan="1" colspan="1">21</td><td valign="middle" align="center" rowspan="1" colspan="1">6</td><td valign="middle" align="center" rowspan="1" colspan="1">0.006*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Cirrhosis</td><td valign="middle" align="center" rowspan="1" colspan="1">22</td><td valign="middle" align="center" rowspan="1" colspan="1">6</td><td valign="middle" align="center" rowspan="1" colspan="1">0.003*</td></tr></tbody></table><table-wrap-foot><fn><p>SD, standard deviation; AFP, Alpha-Fetoprotein; *, <italic>P</italic> &#x0003c; 0.05; HCC, hepatocellular carcinoma; ICC, intrahepatic&#x000a0;cholangiocarcinoma.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3_2"><title>Correlation between the mean values of CTRW-, RSI- and ADC-Derived Parameters</title><p>Spearman correlation analysis revealed several correlations, notably, D<sub>mean</sub> and f<sub>1 mean</sub> exhibited a strong negative correlation (r = -0.869, <italic>P&#x0003c;</italic> 0.0001), while D<sub>mean</sub> and ADC <sub>mean</sub> showed a strong positive correlation (r = 0.887, <italic>P&#x0003c;</italic> 0.0001). A moderate negative correlation was observed between f<sub>1 mean</sub> and ADC <sub>mean</sub> (r = -0.716, <italic>P&#x0003c;</italic> 0.0001), and similarly between &#x003b1;<sub>mean</sub> and f<sub>1 mean</sub> (r = -0.698, <italic>P&#x0003c;</italic> 0.0001). Furthermore, moderate positive correlations were found between D<sub>mean</sub> and f<sub>3 mean</sub> (r = 0.556, <italic>P&#x0003c;</italic> 0.0001), &#x003b2;<sub>mean</sub> and f<sub>2 mean</sub> (r = 0.661, <italic>P&#x0003c;</italic> 0.0001), as well as between f<sub>3 mean</sub> and ADC <sub>mean</sub> (r = 0.749, <italic>P&#x0003c;</italic> 0.0001). Other correlations among the parameters were not statistically significant.</p></sec><sec id="s3_4"><title>Comparison of histogram-derived parameters between HCC and ICC</title><p>D<sub>mean</sub>, D<sub>median</sub>, D<sub>40th</sub>, D<sub>60th</sub> and D<sub>80th</sub> were significantly lower in HCC patients compared to ICC patients (P = 0.037, 0.049, 0.049, 0.040, and 0.037, respectively). Additionally, f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub>, and f<sub>1 60th</sub> were significantly higher in HCC patients compared to ICC patients (P = 0.024, 0.031, 0.022, and 0.046, respectively). No significant differences were observed in the other parameters, as shown in <xref rid="T3" ref-type="table">
<bold>Table&#x000a0;3</bold>
</xref> and <xref rid="f4" ref-type="fig">
<bold>Figure&#x000a0;4</bold>
</xref>.</p><table-wrap position="float" id="T3"><label>Table&#x000a0;3</label><caption><p>Comparison of Histogram-Derived Parameters between HCC and ICC.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Parameter</th><th valign="middle" align="center" rowspan="1" colspan="1">HCC ( N = 25 ) Median (IQR)</th><th valign="middle" align="center" rowspan="1" colspan="1">ICC ( N = 15 ) Median (IQR)</th><th valign="middle" align="center" rowspan="1" colspan="1">Z</th><th valign="middle" align="center" rowspan="1" colspan="1">P</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>mean</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.827 (0.730, 0.979)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.939 (0.860, 1.196)</td><td valign="middle" align="center" rowspan="1" colspan="1">2.081</td><td valign="middle" align="center" rowspan="1" colspan="1">0.037</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>median</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.805 (0.729, 0.958)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.936 (0.831, 1.216)</td><td valign="middle" align="center" rowspan="1" colspan="1">1.970</td><td valign="middle" align="center" rowspan="1" colspan="1">0.049</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>40th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.773 (0.675, 0.916)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.904 (0.803, 1.107)</td><td valign="middle" align="center" rowspan="1" colspan="1">1.970</td><td valign="middle" align="center" rowspan="1" colspan="1">0.049</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>60th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.846 (0.765, 1.021)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.963 (0.878, 1.330)</td><td valign="middle" align="center" rowspan="1" colspan="1">2.053</td><td valign="middle" align="center" rowspan="1" colspan="1">0.040</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>80th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.951 (0.893, 1.168)</td><td valign="middle" align="center" rowspan="1" colspan="1">1.162 (0.977, 1.583)</td><td valign="middle" align="center" rowspan="1" colspan="1">2.081</td><td valign="middle" align="center" rowspan="1" colspan="1">0.037</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 median</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.167 (0.103, 0.215)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.090 (0.050, 0.162)</td><td valign="middle" align="center" rowspan="1" colspan="1">2.253</td><td valign="middle" align="center" rowspan="1" colspan="1">0.024</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 20th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.106 (0.599, 0.147)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.056 (0.050, 0.109)</td><td valign="middle" align="center" rowspan="1" colspan="1">2.152</td><td valign="middle" align="center" rowspan="1" colspan="1">0.031</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 40th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.154 (0.090, 0.188)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.079 (0.050, 0.134)</td><td valign="middle" align="center" rowspan="1" colspan="1">2.290</td><td valign="middle" align="center" rowspan="1" colspan="1">0.022</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 60th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.184 (0.121, 0.242)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.125 (0.063, 0.180)</td><td valign="middle" align="center" rowspan="1" colspan="1">1.999</td><td valign="middle" align="center" rowspan="1" colspan="1">0.046</td></tr></tbody></table><table-wrap-foot><fn><p>HCC, hepatocellular carcinoma; ICC, intrahepatic&#x000a0;cholangiocarcinoma; IQR, Interquartile Range; D, diffusion coefficient; <italic>f</italic>
<sub>1,</sub> the signal fraction of restricted diffusion; D <sub>mean</sub>, D <sub>median</sub>, D <sub>40th</sub>, D <sub>60th</sub> and D <sub>80th</sub> represent the mean, median, 40th percentile, 60th percentile and 80th percentile of the D in the continuous-time random walk, respectively; <italic>f</italic>
<sub>1 median</sub>, <italic>f</italic>
<sub>1 20th</sub>, <italic>f</italic>
<sub>1 40th</sub> and <italic>f</italic>
<sub>1 60th</sub> represent the median, 20th percentile, 40th percentile and 60th percentile of the <italic>f</italic>
<sub>1</sub> in the Tri-Compartmental restriction spectrum imaging model, respectively. D <sub>mean</sub>, D <sub>median</sub>, D <sub>40th</sub>, D <sub>60th</sub> and D <sub>80th</sub> are expressed in units of &#x000d7;10<sup>-3</sup> square millimeters per second (mm<sup>2</sup>/s); <italic>f</italic>
<sub>1 median</sub>, <italic>f</italic>
<sub>1 20th</sub>, <italic>f</italic>
<sub>1 40th</sub> and <italic>f</italic>
<sub>1 60th</sub> are unitless. Mann-Whitney U test was used for group comparison.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="f4"><label>Figure&#x000a0;4</label><caption><p>
<bold>(a-i)</bold> Comparison of different parameters (D <sub>mean</sub>, D <sub>median</sub>, D <sub>40th</sub>, D <sub>60th</sub>, D <sub>80th</sub>, f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub> and f<sub>1 60th</sub>) between the HCC group and the ICC group.</p></caption><graphic xlink:href="fonc-15-1516995-g004" position="float"/></fig></sec><sec id="s3_5"><title>Diagnostic performance of histogram-derived parameters in distinguishing pathological subtypes of liver cancer</title><p>Individual histogram parameters D<sub>mean</sub>, D<sub>median</sub>, D<sub>40th</sub>, D<sub>60th</sub>, D<sub>80th</sub>, f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub>, and f<sub>1 60th</sub>, along with combined models - total (a combination of D<sub>mean</sub>, D<sub>median</sub>, D<sub>40th</sub>, D<sub>60th</sub>, D<sub>80th</sub>, f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub>, and f<sub>1 60th</sub>), CTRW combined model (D, &#x003b1;, and &#x003b2;), RSI combined model (combining f<sub>1</sub>, f<sub>2</sub>, and f<sub>3</sub>), and CTRW+RSI combined model - all demonstrated statistically significant ROC curves. AUC values of total, f<sub>1 40</sub>
<sup>th</sup>, f<sub>1 median</sub>, f<sub>1 20</sub>
<sup>th</sup>, D<sub>80th</sub>, D<sub>mean</sub>, D<sub>60th</sub>, f<sub>1 60th</sub>, D<sub>40th</sub>, and D<sub>median</sub> were 0.792, 0.717, 0.715, 0.703, 0.699, 0.699, 0.696, 0.691, 0.688, and 0.688, respectively. The combined models demonstrated significantly higher diagnostic performance, and among individual parameters, the combined models showed the best sensitivity. Regarding the CTRW, RSI, and CTRW+RSI combined models, their diagnostic efficiencies in distinguishing HCC and ICC were ranked as follows: AUC (CTRW+RSI) &#x0003e; AUC (RSI) &#x0003e; AUC (CTRW), with AUC values of 0.787, 0.731, and 0.717, respectively. Although RSI exhibited better diagnostic performance than CTRW in differentiating the pathological subtypes of liver cancer, the combination of CTRW and RSI improved diagnostic efficiency, providing the highest sensitivity and specificity (<xref rid="T4" ref-type="table">
<bold>Table&#x000a0;4</bold>
</xref>, <xref rid="f5" ref-type="fig">
<bold>Figure&#x000a0;5</bold>
</xref>).</p><table-wrap position="float" id="T4"><label>Table&#x000a0;4</label><caption><p>ROC Analysis of the Diagnostic Performance for Different Parameters and Methods Alone or in Combination for Distinguishing HCC from ICC.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Parameters</th><th valign="middle" align="center" rowspan="1" colspan="1">AUC(95% CI)</th><th valign="middle" align="center" rowspan="1" colspan="1">Cut off</th><th valign="middle" align="center" rowspan="1" colspan="1">Sensitivity(95% CI)</th><th valign="middle" align="center" rowspan="1" colspan="1">Specificity(95% CI)</th><th valign="middle" align="center" rowspan="1" colspan="1">Youden Index</th><th valign="middle" align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td valign="middle" align="left" rowspan="1" colspan="1">D<sub>mean</sub> (&#x000d7;10<sup>-3</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.699 (0.533-0.833)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.831</td><td valign="middle" align="center" rowspan="1" colspan="1">0.560 (0.349-0.756)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.867 (0.595-0.983)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.427</td><td valign="middle" align="center" rowspan="1" colspan="1">0.037*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D<sub>median</sub> (&#x000d7;10<sup>-3</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.688 (0.522-0.825)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.805</td><td valign="middle" align="center" rowspan="1" colspan="1">0.520 (0.313-0.722)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.867 (0.595-0.983)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.387</td><td valign="middle" align="center" rowspan="1" colspan="1">0.049*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>40th</sub> (&#x000d7;10<sup>-3</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.688 (0.522-0.825)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.826</td><td valign="middle" align="center" rowspan="1" colspan="1">0.720 (0.506-0.879)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.667 (0.384-0.882)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.387</td><td valign="middle" align="center" rowspan="1" colspan="1">0.049*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>60th</sub> (&#x000d7;10<sup>-3</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.696 (0.530-0.831)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.857</td><td valign="middle" align="center" rowspan="1" colspan="1">0.560 (0.349-0.756)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.867 (0.595-0.983)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.426</td><td valign="middle" align="center" rowspan="1" colspan="1">0.040*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">D <sub>80th</sub> (&#x000d7;10<sup>-3</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.699 (0.533-0.833)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.950</td><td valign="middle" align="center" rowspan="1" colspan="1">0.520 (0.313-0.722)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.867(0.595-0.983)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.386</td><td valign="middle" align="center" rowspan="1" colspan="1">0.037*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 median</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.715 (0.550-0.846)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.162</td><td valign="middle" align="center" rowspan="1" colspan="1">0.600 (0.387-0.789)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.867 (0.595-0.983)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.467</td><td valign="middle" align="center" rowspan="1" colspan="1">0.025*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 20th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.703 (0.537-0.836)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.077</td><td valign="middle" align="center" rowspan="1" colspan="1">0.680 (0.465-0.851)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.733 (0.449-0.922)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.413</td><td valign="middle" align="center" rowspan="1" colspan="1">0.034*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 40th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.717 (0.553-0.848)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.133</td><td valign="middle" align="center" rowspan="1" colspan="1">0.640 (0.425-0.820)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.800 (0.519-0.957)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.440</td><td valign="middle" align="center" rowspan="1" colspan="1">0.023*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">
<italic>f</italic>
<sub>1 60th</sub>
</td><td valign="middle" align="center" rowspan="1" colspan="1">0.691 (0.525-0.827)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.154</td><td valign="middle" align="center" rowspan="1" colspan="1">0.720 (0.506-0.879)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.667 (0.384-0.882)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.387</td><td valign="middle" align="center" rowspan="1" colspan="1">0.046*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Total</td><td valign="middle" align="center" rowspan="1" colspan="1">0.792 (0.634-0.904)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.579</td><td valign="middle" align="center" rowspan="1" colspan="1">1.000 (0.863-1.000)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.533 (0.266-0.787)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.533</td><td valign="middle" align="center" rowspan="1" colspan="1">0.002*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">CTRW</td><td valign="middle" align="center" rowspan="1" colspan="1">0.717 (0.553-0.848)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.353</td><td valign="middle" align="center" rowspan="1" colspan="1">0.640 (0.428-0.820)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.800(0.519-0.957)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.440</td><td valign="middle" align="center" rowspan="1" colspan="1">0.023*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">RSI</td><td valign="middle" align="center" rowspan="1" colspan="1">0.731 (0.567-0.858)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.379</td><td valign="middle" align="center" rowspan="1" colspan="1">0.680 (0.465-0.851)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.800 (0.519-0.957)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.480</td><td valign="middle" align="center" rowspan="1" colspan="1">0.016*</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">ADC<sub>mean</sub>(&#x000d7;10<sup>-3</sup>)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.637 (0.470-0.783)</td><td valign="middle" align="center" rowspan="1" colspan="1">1.199</td><td valign="middle" align="center" rowspan="1" colspan="1">0.600 (0.387-0.789)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.733 (0.449-0.922)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.333</td><td valign="middle" align="center" rowspan="1" colspan="1">0.150</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">CTRW+RSI</td><td valign="middle" align="center" rowspan="1" colspan="1">0.787 (0.628-0.900)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.318</td><td valign="middle" align="center" rowspan="1" colspan="1">0.720 (0.506-0.879)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.800 (0.519-0.957)</td><td valign="middle" align="center" rowspan="1" colspan="1">0.520</td><td valign="middle" align="center" rowspan="1" colspan="1">0.003*</td></tr></tbody></table><table-wrap-foot><fn><p>ROC, Receiver Operating Characteristic; HCC, hepatocellular carcinoma; ICC, intrahepatic&#x000a0;cholangiocarcinoma; AUC, Area Under the Curve; CI, Confidence Interval; D, diffusion coefficient; <italic>f</italic>
<sub>1,</sub> the signal fraction of restricted diffusion; D <sub>mean</sub>, D <sub>median</sub>, D <sub>40th</sub>, D <sub>60th</sub> and D <sub>80th</sub> represent the mean, median, 40th percentile, 60th percentile and 80th percentile of the D in the continuous-time random walk, respectively; <italic>f</italic>
<sub>1 median</sub>, <italic>f</italic>
<sub>1 20th</sub>, <italic>f</italic>
<sub>1 40th</sub> and <italic>f</italic>
<sub>1 60th</sub> represent the median, 20th percentile, 40th percentile and 60th percentile of the <italic>f</italic>
<sub>1</sub> in the Tri-Compartmental restriction spectrum imaging model, respectively; *, <italic>P</italic> &#x0003c; 0.05; CTRW, continuous-time random walk; RSI, restriction spectrum imaging; ADC, apparent diffusion coefficient. D <sub>mean</sub>, D <sub>median</sub>, D <sub>40th</sub>, D <sub>60th</sub> and D <sub>80th</sub> are expressed in units of &#x000d7;10<sup>-3</sup>square millimeters per second (mm<sup>2</sup>/s); <italic>f</italic>
<sub>1 median</sub>, <italic>f</italic>
<sub>1 20th</sub>, <italic>f</italic>
<sub>1 40th</sub> and <italic>f</italic>
<sub>1 60th</sub> are unitless.</p></fn></table-wrap-foot></table-wrap><fig position="float" id="f5"><label>Figure&#x000a0;5</label><caption><p>
<bold>(a-b)</bold> The ROC curves for CTRW-derived histogram parameters (D <sub>mean</sub>, D <sub>median</sub>, D <sub>40th</sub>, D <sub>60th</sub>, D <sub>80th</sub>) and RSI-derived histogram parameters (f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub>, f<sub>1 60th</sub>) distinguishing between the HCC group and the ICC group. <bold>(c)</bold> The ROC curves for CTRW, RSI, the combined model (CTRW+RSI) and the total combined model (D <sub>mean</sub>, D <sub>median</sub>, D <sub>40th</sub>, D <sub>60th</sub>, D <sub>80th</sub>, f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub> and f<sub>1 60th</sub>) distinguishing between the HCC group and the ICC group.</p></caption><graphic xlink:href="fonc-15-1516995-g005" position="float"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>This study represents a significant and pioneering effort in evaluating the diagnostic capabilities of two advanced, non-Gaussian diffusion-weighted models, CTRW and RSI, in distinguishing HCC from ICC. The results demonstrated that both the CTRW and RSI models effectively distinguish between HCC and ICC. Notably, the RSI model exhibited superior diagnostic performance compared to the CTRW, with the signal fraction of restricted diffusion (f<sub>1</sub>) from RSI showing greater potential for differentiating HCC from ICC. Moreover, combining histogram parameters or integrating multiple diffusion models significantly enhanced diagnostic accuracy. The combined histogram parameter model demonstrated the highest diagnostic efficacy among all approaches tested. This study establishes the potential of these models to improve diagnostic accuracy and provides a foundation for future research into their broader clinical application, particularly in the context of liver cancer subtyping.</p><p>A substantial body of research suggests that the ADC values derived from the mono-exponential model are based on the assumption that water molecule diffusion follows a Gaussian distribution (<xref rid="B28" ref-type="bibr">28</xref>). However, the actual microenvironment within biological tissues, especially in heterogeneous tumors, is far more complex. In such environments, the movement of water molecules is restricted by cellular structures and membranes, resulting in non-Gaussian diffusion behavior (<xref rid="B11" ref-type="bibr">11</xref>). Consequently, ADC values fail to account for the non-Gaussian characteristics of water diffusion within these intricate subcellular microstructures, limiting their diagnostic efficacy (<xref rid="B12" ref-type="bibr">12</xref>). This aligns with our study&#x02019;s findings, which indicate that ADC values are suboptimal for distinguishing between pathological subtypes of liver cancer.</p><p>The RSI separates the diffusion of water molecules in tissues into restricted diffusion, hindered diffusion, and free water diffusion, and its parameters f<sub>1</sub>, f<sub>2</sub>, and f<sub>3</sub> represent the proportions in which the above three compartments are located, typically summing to 1. In this study, the f<sub>1 median</sub>, f<sub>1 20th</sub>, f<sub>1 40th</sub>, and f<sub>1 60th</sub> values were significantly higher in HCC patients compared to ICC patients, which may be related to the fact that HCC usually have higher cell densities and more tightly packed cells (<xref rid="B29" ref-type="bibr">29</xref>). Also in this study, we found that none of the differences in f<sub>2</sub> and f<sub>3</sub> between HCC and ICC were statistically significant. This is similar to the study by Xiong et&#x000a0;al. (<xref rid="B30" ref-type="bibr">30</xref>), and we hypothesize that this may be related to the fact that the fitting of f<sub>2</sub> and f<sub>3</sub> values is susceptible to the number and size of b-values.</p><p>The CTRW model has three quantitative parameters, namely, D, &#x003b1;, and &#x003b2;. The rate parameter D is mainly used to reflect the speed of the diffusion of water molecules. The present work found that the D values (including D<sub>mean</sub>, D<sub>median</sub>, D<sub>40th</sub>, D<sub>60th</sub>, and D<sub>80th</sub>) were significantly lower in HCC patients. One possible explanation is that HCC is characterized by a higher cell density and more complex microstructure, which restricts the free movement of water molecules. In contrast, the central region of ICC consists of loose fibrous tissue, with tumor cells predominantly located at the periphery, often arranged into adenoidal patterns. This structural arrangement in ICC facilitates the diffusion of water molecules (<xref rid="B31" ref-type="bibr">31</xref>). The &#x003b1; and &#x003b2; describe the potential of water molecules to be retained or released during diffusion. There were no significant differences in both &#x003b1; and &#x003b2; between HCC and ICC in this study, which is not consistent with previous study (<xref rid="B16" ref-type="bibr">16</xref>). We consider that this may be related to the small sample size in this study and the different fitted b values used between studies.</p><p>This investigation also explore the correlations between mean histogram-derived parameters from these advanced models. The Spearman correlation analysis revealed a strong negative correlation between D<sub>mean</sub> and f<sub>1 mean</sub>, a strong positive correlation between D<sub>mean</sub> and ADC <sub>mean</sub>, and a moderate negative correlation between f<sub>1 mean</sub> and ADC <sub>mean</sub>, indicating their association with tissue cellular structures (<xref rid="B32" ref-type="bibr">32</xref>). These findings support the consistency of these parameters in assessing tumor tissue characteristics. Theoretically, smaller &#x003b1; and &#x003b2; values suggest a more heterogeneous spatial environment (<xref rid="B33" ref-type="bibr">33</xref>), while f<sub>1</sub>, f<sub>2</sub>, and f<sub>3</sub> correspond to intracellular restricted water, extracellular restricted water, and freely diffusing water, respectively (<xref rid="B20" ref-type="bibr">20</xref>). Further analysis demonstrated a moderate negative correlation between &#x003b1; <sub>mean</sub> and f<sub>1 mean</sub>, as well as a moderate positive correlation between &#x003b2;<sub>mean</sub> and f<sub>2 mean</sub>. This suggests that as cellular density increases, water molecules encounter more obstacles or irregularities during their movement between cells, leading to a greater proportion of water molecules being confined to intracellular spaces. Consequently, this results in an increase in the fraction of restricted diffusion (f<sub>1</sub>) and a decrease in the fraction of extracellular restricted water (f<sub>2</sub>). The observed correlations between diffusion parameters not only support the theoretical associations between specific parameters in these different diffusion models, but also have the potential to provide markers for tumor characterization assessment, such as monitoring cell morphology and density changes during treatment by f1-f2-ADC alterations. However, there are few relevant studies yet, and further large sample size experimental observation is still needed in the future.</p><p>In this study, the results indicate that both CTRW and RSI outperform traditional DWI-ADC in differentiating between HCC and ICC, with RSI exhibiting the highest discriminatory power. This superiority is likely due to the non-Gaussian distribution characteristics of CTRW and RSI, which, unlike the Gaussian assumptions of the ADC model, accurately reflect the complex diffusion behavior of water molecules and the intricate microstructure of tumor tissues (<xref rid="B13" ref-type="bibr">13</xref>). In addition, the high diagnostic performance of RSI may be attributed to the ability to isolate genuinely restricted diffusion areas, thereby minimizing interference from extracellular diffusion signals (<xref rid="B34" ref-type="bibr">34</xref>). This allows RSI to more directly measure tumor cell density and tissue structure, making the difference in high cell density regions between HCC and ICC more pronounced. Although CTRW and RSI represent significant advancements in DW-MRI, no single imaging technique currently fulfills all diagnostic requirements for tumors. Our study demonstrates that both the combined models of CTRW and RSI, as well as the integrated models of histogram parameters showing statistically significant differences between the pathological subtypes of liver cancer, provide superior diagnostic performance compared to individual models or histogram parameters used in isolation. This enhanced performance is attributed to the comprehensive integration of multidimensional information, including cellular metabolism and water molecule diffusion, which provides valuable complementary insights. Therefore, where possible, adopting multimodal imaging approaches for lesion assessment is likely to yield the greatest diagnostic benefits. By leveraging the strengths of various imaging techniques, clinicians can obtain a more holistic understanding of tumor characteristics, ultimately leading to more accurate diagnoses and better patient management.</p></sec><sec id="s5"><title>Limitations</title><p>Firstly, it was a single-center and relatively small sample size study Secondly, no test-retest procedure was implemented for diffusion MRI within the same participants. The Quantitative Imaging Biomarkers Alliance advocates for such retest procedures to assess the repeatability and reproducibility of quantitative MRI techniques. Thirdly, the scans in this study were performed a single imaging vendor or scanner. These limitations suggest that while our findings are promising, caution should be exercised in generalizing the results until further research can provide more robust validation. In the future, we will include more patients and conduct multicenter studies at different institutions, and will further optimize the parameters, port the relevant scanning protocols to different devices, and conduct external validation of the relevant parameter measurements with a view to improving the fitness and reducing the bias.</p></sec><sec sec-type="conclusions" id="s6"><title>Conclusion</title><p>In summary, both the CTRW and RSI models, along with their derived histogram parameters, demonstrated the ability to differentiate between pathological subtypes of liver cancer, whether utilized individually or in combination. Furthermore, whole-lesion histogram parameters provide richer statistical information compared to mean values, offering a quantitative approach to analyzing subtle changes in tumor voxels. This advancement has the potential to find an accurate, noninvasive imaging marker for the differentiation of HCC and ICC, which could help reduce unnecessary biopsies, especially in resource-limited settings, and in turn guide clinical decision-making.</p></sec></body><back><sec sec-type="data-availability" id="s7"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec sec-type="ethics-statement" id="s8"><title>Ethics statement</title><p>The studies involving humans were approved by Henan Provincial People&#x02019;s Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants&#x02019; legal guardians/next of kin.</p></sec><sec sec-type="author-contributions" id="s9"><title>Author contributions</title><p>BD: Writing &#x02013; original draft. YZ: Conceptualization, Writing &#x02013; original draft. LS: Conceptualization, Writing &#x02013; review &#x00026; editing. HL: Investigation, Methodology, Writing &#x02013; original draft. TF: Data curation, Formal analysis, Writing &#x02013; review &#x00026; editing. JP: Software, Supervision, Writing &#x02013; review &#x00026; editing. YW: Software, Supervision, Writing &#x02013; review &#x00026; editing. WM: Visualization, Software, Writing &#x02013; review &#x00026; editing. XS: Software, Supervision, Writing &#x02013; review &#x00026; editing. FY: Validation, Writing &#x02013; review &#x00026; editing. MW: Formal analysis, Project administration, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="s11"><title>Conflict of interest</title><p>Authors WM and XS were employed by GE Healthcare.</p><p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s12"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s13"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Paul</surname><given-names>B</given-names></name><name><surname>Lewinska</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>JB</given-names></name></person-group>. <article-title>Lipid alterations in chronic liver disease and liver cancer</article-title>. <source>JHEP Reports: Innovation Hepatol</source>. (<year>2022</year>) <volume>4</volume>:<fpage>100479</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jhepr.2022.100479</pub-id>
</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rumgay</surname><given-names>H</given-names></name><name><surname>Arnold</surname><given-names>M</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Lesi</surname><given-names>O</given-names></name><name><surname>Cabasag</surname><given-names>CJ</given-names></name><name><surname>Vignat</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Global burden of primary liver cancer in 2020 and predictions to 2040</article-title>. <source>J Hepatol</source>. (<year>2022</year>) <volume>77</volume>:<page-range>1598&#x02013;606</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jhep.2022.08.021</pub-id>
</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>YT</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Luu</surname><given-names>M</given-names></name><name><surname>Noureddin</surname><given-names>M</given-names></name><name><surname>Nissen</surname><given-names>NN</given-names></name><name><surname>Patel</surname><given-names>TC</given-names></name><etal/></person-group>. <article-title>Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States</article-title>. <source>Hepatol (Baltimore Md)</source>. (<year>2021</year>) <volume>74</volume>:<page-range>2622&#x02013;32</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/hep.32007</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yi</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Proteome landscapes of human hepatocellular carcinoma and intrahepatic cholangiocarcinoma</article-title>. <source>Mol Cell proteomics: MCP</source>. (<year>2023</year>) <volume>22</volume>:<fpage>100604</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.mcpro.2023.100604</pub-id>
<pub-id pub-id-type="pmid">37353004</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>An</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Byun</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Jeong</surname><given-names>WK</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><etal/></person-group>. <article-title>Intraindividual comparison between gadoxetate-enhanced magnetic resonance imaging and dynamic computed tomography for characterizing focal hepatic lesions: A multicenter, multireader study</article-title>. <source>Korean J Radiol</source>. (<year>2019</year>) <volume>20</volume>:<page-range>1616&#x02013;26</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3348/kjr.2019.0363</pub-id>
</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jang</surname><given-names>HJ</given-names></name><name><surname>Go</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name></person-group>. <article-title>Deep learning for the pathologic diagnosis of hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer</article-title>. <source>Cancers</source>. (<year>2023</year>) <volume>15</volume>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3390/cancers15225389</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saleh</surname><given-names>GA</given-names></name><name><surname>Elmokadem</surname><given-names>AH</given-names></name><name><surname>Razek</surname><given-names>AA</given-names></name><name><surname>El-Morsy</surname><given-names>A</given-names></name><name><surname>Hamdy</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Utility of diffusion tensor imaging in differentiating benign from Malignant hepatic focal lesions</article-title>. <source>Eur Radiol</source>. (<year>2023</year>) <volume>33</volume>:<page-range>1400&#x02013;11</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00330-022-09091-w</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karim</surname><given-names>S</given-names></name><name><surname>Seidensticker</surname><given-names>R</given-names></name><name><surname>Seidensticker</surname><given-names>M</given-names></name><name><surname>Ricke</surname><given-names>J</given-names></name><name><surname>Schinner</surname><given-names>R</given-names></name><name><surname>Treitl</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases</article-title>. <source>Radiol Oncol</source>. (<year>2024</year>) <volume>58</volume>:<fpage>33</fpage>&#x02013;<lpage>42</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.2478/raon-2024-0017</pub-id>
<pub-id pub-id-type="pmid">38378033</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Surov</surname><given-names>A</given-names></name><name><surname>Eger</surname><given-names>KI</given-names></name><name><surname>Potratz</surname><given-names>J</given-names></name><name><surname>Gottschling</surname><given-names>S</given-names></name><name><surname>Wienke</surname><given-names>A</given-names></name><name><surname>Jechorek</surname><given-names>D</given-names></name></person-group>. <article-title>Apparent diffusion coefficient correlates with different histopathological features in several intrahepatic tumors</article-title>. <source>Eur Radiol</source>. (<year>2023</year>) <volume>33</volume>:<page-range>5955&#x02013;64</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00330-023-09788-6</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fokkinga</surname><given-names>E</given-names></name><name><surname>Hernandez-Tamames</surname><given-names>JA</given-names></name><name><surname>Ianus</surname><given-names>A</given-names></name><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Tax</surname><given-names>CMW</given-names></name><name><surname>Perez-Lopez</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Advanced diffusion-weighted MRI for cancer microstructure assessment in body imaging, and its relationship with histology</article-title>. <source>J Magn Reson Imaging.</source> (<year>2024</year>) <volume>60</volume>:<page-range>1278&#x02013;304</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/jmri.29144</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Comparison of continuous-time random walk and fractional order calculus models in characterizing breast lesions using histogram analysis</article-title>. <source>Magn Reson Imaging.</source> (<year>2024</year>) <volume>108</volume>:<fpage>47</fpage>&#x02013;<lpage>58</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.mri.2024.01.012</pub-id>
<pub-id pub-id-type="pmid">38307375</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Dang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Preoperative prediction of VETC in hepatocellular carcinoma using non-Gaussian diffusion-weighted imaging at high b values: a pilot study</article-title>. <source>Front Oncol</source>. (<year>2023</year>) <volume>13</volume>
<elocation-id>:1167209.</elocation-id> doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fonc.2023.1167209</pub-id>
<pub-id pub-id-type="pmid">37305565</pub-id>
</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fan</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Non-Gaussian diffusion metrics with whole-tumor histogram analysis for bladder cancer diagnosis: muscle invasion and histological grade</article-title>. <source>Insights Imaging.</source> (<year>2024</year>) <volume>15</volume>:<fpage>138</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s13244-024-01701-z</pub-id>
<pub-id pub-id-type="pmid">38853200</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mao</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Discrimination between human epidermal growth factor receptor 2 (HER2)-low-expressing and HER2-overexpressing breast cancers: a comparative study of four MRI diffusion models</article-title>. <source>Eur Radiol</source>. (<year>2024</year>) <volume>34</volume>:<page-range>2546&#x02013;59</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00330-023-10198-x</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mehta</surname><given-names>R</given-names></name><name><surname>Bu</surname><given-names>Y</given-names></name><name><surname>Zhong</surname><given-names>Z</given-names></name><name><surname>Dan</surname><given-names>G</given-names></name><name><surname>Zhong</surname><given-names>PS</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Characterization of breast lesions using multi-parametric diffusion MRI and machine learning</article-title>. <source>Phys Med Biol</source>. (<year>2023</year>) <volume>68</volume>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1088/1361-6560/acbde0</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xiang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>YX</given-names></name><name><surname>Kong</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Evaluation of breast cancer Malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model</article-title>. <source>Eur J Radiol</source>. (<year>2023</year>) <volume>166</volume>:<fpage>111003</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.ejrad.2023.111003</pub-id>
<pub-id pub-id-type="pmid">37506477</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>YL</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>PF</given-names></name><name><surname>Fan</surname><given-names>FX</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Staging liver fibrosis with various diffusion-weighted magnetic resonance imaging models</article-title>. <source>World J Gastroenterol</source>. (<year>2024</year>) <volume>30</volume>:<page-range>1164&#x02013;76</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3748/wjg.v30.i9.1164</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ai</surname><given-names>T</given-names></name></person-group>. <article-title>Quantitative characterization of breast lesions and normal fibroglandular tissue using compartmentalized diffusion-weighted model: comparison of intravoxel incoherent motion and restriction spectrum imaging</article-title>. <source>Breast Cancer research: BCR</source>. (<year>2024</year>) <volume>26</volume>:<fpage>71</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s13058-024-01828-3</pub-id>
<pub-id pub-id-type="pmid">38658999</pub-id>
</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Meng</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Restriction spectrum imaging and diffusion kurtosis imaging for assessing proliferation status in rectal carcinoma</article-title>. <source>Acad Radiol</source>. (<year>2025</year>) <volume>32</volume>:<page-range>201&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.acra.2024.08.021</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Xue</surname><given-names>Q</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>The value of restriction spectrum imaging in predicting lymph node metastases in rectal cancer: a comparative study with diffusion-weighted imaging and diffusion kurtosis imaging</article-title>. <source>Insights Imaging.</source> (<year>2024</year>) <volume>15</volume>:<fpage>302</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s13244-024-01852-z</pub-id>
<pub-id pub-id-type="pmid">39699826</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eng</surname><given-names>SE</given-names></name><name><surname>Basasie</surname><given-names>B</given-names></name><name><surname>Lam</surname><given-names>A</given-names></name><name><surname>John Semmes</surname><given-names>O</given-names></name><name><surname>Troyer</surname><given-names>DA</given-names></name><name><surname>Clarke</surname><given-names>GD</given-names></name><etal/></person-group>. <article-title>Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy</article-title>. <source>Prostate Cancer Prostatic Dis</source>. (<year>2024</year>) <volume>27</volume>:<fpage>65</fpage>&#x02013;<lpage>72</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41391-022-00591-w</pub-id>
<pub-id pub-id-type="pmid">36097168</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kurokawa</surname><given-names>R</given-names></name><name><surname>Baba</surname><given-names>A</given-names></name><name><surname>Kurokawa</surname><given-names>M</given-names></name><name><surname>Capizzano</surname><given-names>A</given-names></name><name><surname>Hassan</surname><given-names>O</given-names></name><name><surname>Johnson</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Pretreatment ADC histogram analysis as a prognostic imaging biomarker for patients with recurrent glioblastoma treated with bevacizumab: A systematic review and meta-analysis</article-title>. <source>AJNR Am J neuroradiology</source>. (<year>2022</year>) <volume>43</volume>:<page-range>202&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3174/ajnr.A7406</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Hippe</surname><given-names>DS</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Mayr</surname><given-names>NA</given-names></name><etal/></person-group>. <article-title>Whole-lesion DCE-MRI intensity histogram analysis for diagnosis in patients with suspected lung cancer</article-title>. <source>Acad Radiol</source>. (<year>2021</year>) <volume>28</volume>:<page-range>e27&#x02013;34</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.acra.2020.01.025</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Correlation between quantitative perfusion histogram parameters of DCE-MRI and PTEN, P-Akt and m-TOR in different pathological types of lung cancer</article-title>. <source>BMC Med Imaging</source>. (<year>2021</year>) <volume>21</volume>:<fpage>73</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s12880-021-00604-5</pub-id>
<pub-id pub-id-type="pmid">33865336</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malayeri</surname><given-names>AA</given-names></name><name><surname>El Khouli</surname><given-names>RH</given-names></name><name><surname>Zaheer</surname><given-names>A</given-names></name><name><surname>Jacobs</surname><given-names>MA</given-names></name><name><surname>Corona-Villalobos</surname><given-names>CP</given-names></name><name><surname>Kamel</surname><given-names>IR</given-names></name><etal/></person-group>. <article-title>Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up</article-title>. <source>Radiographics: Rev Publ Radiological Soc North America Inc</source>. (<year>2011</year>) <volume>31</volume>:<page-range>1773&#x02013;91</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1148/rg.316115515</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Sheng</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>M</given-names></name></person-group>. <article-title>Preoperatively identify the microvascular invasion of hepatocellular carcinoma with the restricted spectrum imaging</article-title>. <source>Acad Radiol</source>. (<year>2023</year>) <volume>30 Suppl 1</volume>:<fpage>S30</fpage>&#x02013;<lpage>s39</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.acra.2023.06.010</pub-id>
<pub-id pub-id-type="pmid">37442719</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lei</surname><given-names>H</given-names></name><name><surname>Du</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors in nasopharyngeal carcinoma</article-title>. <source>Eur Radiol</source>. (<year>2023</year>) <volume>33</volume>:<page-range>5344&#x02013;54</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00330-023-09553-9</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iima</surname><given-names>M</given-names></name><name><surname>Honda</surname><given-names>M</given-names></name><name><surname>Sigmund</surname><given-names>EE</given-names></name><name><surname>Ohno Kishimoto</surname><given-names>A</given-names></name><name><surname>Kataoka</surname><given-names>M</given-names></name><name><surname>Togashi</surname><given-names>K</given-names></name></person-group>. <article-title>Diffusion MRI of the breast: Current status and future directions</article-title>. <source>J magnetic resonance imaging: JMRI</source>. (<year>2020</year>) <volume>52</volume>:<fpage>70</fpage>&#x02013;<lpage>90</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/jmri.26908</pub-id>
<pub-id pub-id-type="pmid">31520518</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Meng</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>F</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Tri-compartmental restriction spectrum imaging based on 18F-FDG PET/MR for identification of primary benign and Malignant lung lesions</article-title>. <source>J Magn Reson Imaging.</source> (<year>2025</year>) <volume>61</volume>:<page-range>830&#x02013;40</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/jmri.29438</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiong</surname><given-names>Z</given-names></name><name><surname>Geng</surname><given-names>Z</given-names></name><name><surname>Lian</surname><given-names>S</given-names></name><name><surname>Yin</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Discriminating rectal cancer grades using restriction spectrum imaging</article-title>. <source>Abdom Radiol (NY).</source> (<year>2022</year>) <volume>47</volume>:<page-range>2014&#x02013;22</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00261-022-03500-w</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Volumetric apparent diffusion coefficient histogram analysis in differentiating intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma</article-title>. <source>J magnetic resonance imaging: JMRI</source>. (<year>2019</year>) <volume>49</volume>:<page-range>975&#x02013;83</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/jmri.26253</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wan</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>YS</given-names></name><name><surname>Zhou</surname><given-names>JX</given-names></name><name><surname>Yu</surname><given-names>YD</given-names></name><name><surname>Bao</surname><given-names>YY</given-names></name><name><surname>Lei</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Intravoxel incoherent motion diffusion-weighted MR imaging in assessing and characterizing solitary pulmonary lesions</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>43257</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/srep43257</pub-id>
<pub-id pub-id-type="pmid">28225064</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>T</given-names></name><name><surname>Ai</surname><given-names>T</given-names></name></person-group>. <article-title>Assessment of prognostic factors and molecular subtypes of breast cancer with a continuous-time random-walk MR diffusion model: using whole tumor histogram analysis</article-title>. <source>J magnetic resonance imaging: JMRI</source>. (<year>2023</year>) <volume>58</volume>:<fpage>93</fpage>&#x02013;<lpage>105</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/jmri.28474</pub-id>
<pub-id pub-id-type="pmid">36251468</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>White</surname><given-names>NS</given-names></name><name><surname>Leergaard</surname><given-names>TB</given-names></name><name><surname>D&#x02019;Arceuil</surname><given-names>H</given-names></name><name><surname>Bjaalie</surname><given-names>JG</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name></person-group>. <article-title>Probing tissue microstructure with restriction spectrum imaging: Histological and theoretical validation</article-title>. <source>Hum Brain Mapp</source>. (<year>2013</year>) <volume>34</volume>:<page-range>327&#x02013;46</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/hbm.21454</pub-id>
</mixed-citation></ref></ref-list></back></article>